Skip to content

The effect of test food intake on deterioration of visual function after VDT work

The effect of test food intake on deterioration of visual function after VDT work - The effect of test food intake on deterioration of visual function after VDT work

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047137
Enrollment
60
Registered
2023-04-30
Start date
2022-05-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Oral intake of test foods Oral intake of placebo foods

Sponsors

Senju Pharmaceutical Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1]Subjects with bilateral distant vision of 0.6 or higher (uncorrected or corrected) [2]Subjects who routinely play TV games, use PC, or perform VDT [3]Subjects who can have an examinations and obsevations as scheduled [4] Subjects who received sufficient explanation about the purpose and content of the trial, had the ability to consent, volunteered to participate after understanding it well, and agreed to participate in the trial in writing

Exclusion criteria

Exclusion criteria: [1]Subjects who have medical history of serious diseases such as liver disease, renal disease, cardiovascular disease, gastrointestinal disease, respiratory disease, hematological disease, autoimmune disease, endocrine system disease, metabolic disease, etc [2]Subjects who have a history of drug allergy or serious food allergy [3]Subjects who continuously used medicines, health foods or supplements that could affect this study [4]Subjects who are judged by the investigator to be inappropriate for the study

Design outcomes

Primary

MeasureTime frame
Visual function

Secondary

MeasureTime frame
Macular pigment optical density Quality of Life Questionnaire

Countries

Japan

Contacts

Public ContactKeisuke Yoshida

Senju Pharmaceutical Co., Ltd New Business Creation and Development

k-yoshida@senju.co.jp06-6201-9610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026